Glutamate and Its Receptors as Therapeutic Targets for Migraine
Neurotherapeutics- United States
doi 10.1007/s13311-018-0616-5
Full Text
Abstract
Available in
Date
March 5, 2018
Authors
Publisher
Springer Science and Business Media LLC
doi 10.1007/s13311-018-0616-5
Available in
March 5, 2018
Springer Science and Business Media LLC